Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- Status
- RECRUITING
- Phase
- PHASE2
MIBG With Dinutuximab +/- Vorinostat
- Status
- COMPLETED
- Phase
- PHASE1
GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Oral Liquid 13-cis-retinoic Acid (13-CRA)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2
- Status
- WITHDRAWN
- Phase
- PHASE1
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Status
- RECRUITING
- Phase
- PHASE3
NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)
- Status
- COMPLETED
- Phase
- PHASE1
Familial Investigations of Childhood Cancer Predisposition
- Status
- RECRUITING
- Phase
- N/A
Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients
- Status
- COMPLETED
- Phase
- PHASE3
18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
- Status
- AVAILABLE
- Phase
- N/A
Dosimetry Guided PRRT With 90Y-DOTATOC
- Status
- WITHDRAWN
- Phase
- PHASE2
Racotumomab in Patients With High-risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
- Status
- UNKNOWN
- Phase
- PHASE4